Eucomed: Barriers to Medical Device Innovation a Problem in EU
Inconsistent compliance with European Union (EU) rules and added costs attributed to funding and reimbursement are hampering the timely launch of new medical technologies, an industry association said.
“These additional requests usually trigger additional cost with no patient safety benefit, reducing the resources that can be made available to research and increasing the so-called ‘time to patient,’” Eucomed told the European Commission.
Eucomed urged the commission to move quickly to transpose and implement the Medical Device Directives and bring member states in line with regulations regarding late payments.
The recent comments were in response to a July consultation on “The Future of Pharmaceuticals for Human Use in Europe,” which was aimed at fomenting public debate on how to improve the regulatory and nonregulatory framework for medicines.